Counts describe this library, not the strength of evidence.
How to read this evidence
Strength, muscle size and function are related but distinct outcomes. Trials and reviews support progressive resistance exercise, while longevity cohorts cannot establish exact safe-dose limits. More complicated prescriptions do not consistently outperform achievable basics.
In a meta-analysis of 20 studies, feedback during lifting raised acute barbell velocity by approximately 8.4% (g = 0.63, 95% CI 0.36-0.90), and visual feedback (g = 1.11) outperformed verbal feedback (g = 0.47). Only 20 studies were pooled, and the jump-performance effect over a training cycle was uncertain (95% CI -0.20 to 0.99).
In 1637 adults aged 60 or older, obesity defined by body fat percentage (BF%) was linked to higher odds of sarcopenia (OR 1.38, 95% CI 1.13-1.69), while obesity defined by BMI was linked to lower odds (OR 0.69, 95% CI 0.56-0.86). This is a single cross-sectional snapshot using bioelectrical impedance, so it cannot show which body composition causes sarcopenia.
Across 41 studies, repeated static stretching over time produced trivial-to-small gains in muscle strength (SMD 0.21, 95% CI 0.10-0.32) and power (SMD 0.19, 95% CI 0.12-0.26) and moderate-to-large gains in flexibility (SMD 0.96, 95% CI 0.70-1.22). Subgroup and meta-regression findings are exploratory, and the abstract does not give the stretching programs' total duration.
Pooling 55 controlled trials in healthy people, resistance training improved range of motion (effect size 0.73, p < 0.001) and did not differ from stretching alone (ES 0.08, p = 0.79). Bodyweight-only training did not help, and the abstract does not report overall study quality, so the stretching conclusion should be read with caution.
In 9,170 older white men from four cohorts, sarcopenia affected only 1.1% (EWGSOP2), 1.7% (SDOC) or 5.3% (modified SDOC), the definitions agreed poorly (kappa = 0.17), yet each was linked to higher mortality (HR 1.76, 2.75 and 1.93). The cohorts were white men only, and sarcopenia was linked to death but not shown to cause it.
Through a modified Delphi process, experts confirmed 17 consensus statements on sarcopenia prevention, assessment and management, including adopting the EWGSOP2 definition; agreement was strongest for healthy lifestyle (100%) and tailored resistance training (92.5%). These are opinion-based recommendations from a small expert panel, not trial results.
Across 21 trials with 1195 migraine patients, strength training (mean difference -3.55 [-6.15, -0.95]) and high-intensity aerobic exercise (-3.13 [-5.28, -0.97]) lowered monthly migraine frequency the most. The ranking relies partly on indirect comparisons, and the topiramate and amitriptyline estimates were imprecise and not clearly different from placebo.
Across 18 acute and 19 longitudinal studies, the velocity-loss cutoff chosen for a set did not change strength or muscle-endurance gains, but higher cutoffs were linked to more hypertrophy (b = 0.006; 95% CI 0.001, 0.012) and lower cutoffs to better jump, sprint and submaximal-velocity performance. Effects depended on exercise, load and trainee, and the review pools varied study designs.
In a meta-analysis of 4 studies drawn from 7 studies of 3353 community-dwelling adults (mean age about 73), older adults with sarcopenia consumed significantly less protein than those without. Most studies were cross-sectional, so low protein could be a result of sarcopenia as well as a cause, and the abstract gives no pooled number.
International journal of environmental research and public health
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
Among 162 167 UK Biobank adults followed for a median of about 10 years, a 5 kg lower handgrip strength was linked to 7% higher risk of depression (HR 1.07) and 8% higher risk of anxiety (HR 1.08). The lowest grip tertile had 24% and 27% higher risks, but this is observational, so weak grip may reflect poorer health rather than cause mood problems.
In 60 women who had finished breast cancer treatment, 12 weeks of two supervised strength sessions a week plus a 10,000-step goal raised full-body muscular strength more than steps alone (0.718, 95% CI 0.361-1.074, P < 0.001, d = 1.04). Fitness, fatigue, mood and quality of life did not improve, and the trial was small.
Journal of cancer survivorship : research and practice
Pooling 10 placebo-controlled trials in community-dwelling adults over 50, vitamin D alone did not improve grip strength, lean mass or general muscle strength, and scores on the short physical performance battery (SPPB) were slightly lower (mean difference -0.23, 95% CI -0.40 to -0.06, P = 0.007). Heterogeneity was high for some outcomes, and the abstract does not give the vitamin D doses.
Among 4044 older adults in the English Longitudinal Study of Ageing, 376 had sarcopenia at baseline, and they had a much higher chance of poor quality of life at 10 years (odds ratio 5.82, 95% CI 3.45-9.82). It is an observational link, and the 5.82 is an odds ratio, not a risk multiplier.
In 50 adults aged 50-79 years, moderate-intensity resistance training (60% of one-repetition maximum) for 24 weeks increased MRI thigh muscle area by 6.8 cm² versus no exercise (P < 0.01), while low intensity (40%) only increased quadriceps area (+2.3 cm², P < 0.05). The trial was small, and the abstract does not report any strength or function outcomes.
Among 2623 Chinese adults with prediabetes followed for 4 years, those in the high normalized grip strength group had lower odds of progressing to diabetes (OR 0.62, 95% CI 0.44 to 0.87) but not of returning to normal glucose (OR 0.94, 95% CI 0.71 to 1.25). This is an observational cohort, so stronger muscles may be a marker of health rather than a protective factor.
In 16 studies with 427 participants, weightlifting training improved weightlifting load (g 1.35) and countermovement jump height (g 0.95) more than traditional resistance training, but differences in sprint speed and change of direction were not significant. Compared with plyometrics, no outcome differed significantly; heterogeneity was high and bias risk was a concern.
Pooling 19 articles, the prevalence of depression among people with sarcopenia was 0.28 (95% CI 0.21 to 0.36), and sarcopenia was associated with depression (adjusted OR 1.57, 95% CI 1.32 to 1.86). Heterogeneity was large (I² 92.2% for prevalence), so the 0.28 figure is an average across very different studies.